Trials / Completed
CompletedNCT01301469
Comparison of HES 130 in Balanced and in Unbalanced Solution
Prospective, Randomized, Double-blind, Controlled, Multicenter Study on the Efficacy and Safety of HES 130/0. 42 in a Balanced Electrolyte Solution vs a HES 130/0.4 in a Sodium Chloride Solution in Elective Surgery Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- B. Braun Melsungen AG · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of HES 130/0.42 in an electrolyte infusion in comparison to HES 130/0.4 in a sodium chloride infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 6% HES 130/0.42 in plasma adapted Ringer's solution | 60 g/l hydroxyethyl starch 130 dissolved in plasma adapted Ringer's solution (balanced solution) |
| DRUG | 6% HES 130/0.4 in a saline solution | 60 g/l Hydroxyethyl starch (HES) with a mean molecular weight of 130 kDalton which is dissolved in a saline solution |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2011-02-23
- Last updated
- 2012-01-05
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01301469. Inclusion in this directory is not an endorsement.